معرفی
Dr Simon Kerr is a Lecturer at Newcastle University specializing in geriatric medicine and aging physiology, with 19 years of active research output (2005-2024). He serves as key co-investigator in the landmark LACE (Leucine And Creatine for Elderly) sarcopenia trial examining physical performance interventions in older adults.
His research spans critical domains of aging health:
- Sarcopenia pathophysiology and therapeutic interventions
- Autonomic dysfunction in cardiovascular regulation
- Cognitive-vascular interactions in aging
- Blood pressure variability and mortality risk
- Carotid sinus hypersensitivity mechanisms
Analysis of 15 recent publications reveals escalating focus on genetic determinants of sarcopenia (BDKRB2, ACE I/D variants) and multimodal interventions. His work consistently bridges molecular mechanisms (TGF-Beta signaling, renin-angiotensin system) with clinical outcomes through rigorous longitudinal and randomized trial designs.
Dr Kerr maintains extensive collaborations with Newcastle's aging research leadership including Professor Avan Sayer and Professor Miles Witham. He contributes significantly to understanding how vascular physiology impacts cognitive trajectories, with particular emphasis on blood pressure dynamics as modifiable risk factors for age-related decline.
As core member of the LACE trial team, he investigates pharmacological (perindopril) and nutritional (leucine) approaches to combat muscle wasting, while his earlier work established foundational links between autonomic function and cerebral outcomes in community-dwelling elders.
